User:Mr. Ibrahem/Atovaquone

Atovaquone, sold under the brand name Mepron, is an medication used to treat and prevent Pneumocystis jirovecii pneumonia (PCP), toxoplasmosis and babesiosis. For PCP it is used in those who cannot take trimethoprim/sulfamethoxazole. It is taken by mouth.

Common side effects include headache, fever, anxiety, trouble sleeping, vivid dreams, nausea, diarrhea, skin rash, and itching. Other side effects may include liver problems and angioedema. Safety in pregnancy and breastfeeding is unclear. It is a quinone, specifically a naphthoquinone.

Atovaquone was approved for medical use in the United States in 1992. It is available as a generic medication. In the United Kingdom 50 doses of 750 mg costs the NHS about £470 as of 2021. This amount in the United States is about 220 USD.